top of page
Photodynamic therapy (PDT) is a cancer treatment that uses a drug, called a photosensitizer or photosensitizing agent, and a particular type of light.

PDT Cancer Center in Indonesia

Establishment of SPC, PT Great Mataram

​

  • PT Buckingham Investment Holdings (“PT Buckingham”) is a subsidiary of Buckingham Investment Limited in Indonesia. 

  • PT Buckingham established a SPC to carry out PDT project. The SPC is PT Great Mataram. It is a Joint-Venture SPC established in Jakarta, Indonesia.

  • It is a JV established jointly by PT Buckingham Holdings Indonesia and PT Mepro. 

  • PT Mepro is a pharmaceutical company of Indonesia. 

  • PT Great Mataram has a pharmaceutical distribution permit. The role of the company is to import pharmaceutical products and to carry on PDT projects. 

  • We will import and distribute photosensitizer.

 

Introduction of Photodynamic therapy

​

  • Photodynamic therapy (PDT) is a form of phototherapy involving light and a photosensitizing chemical substance, used in conjunction with molecular oxygen to elicit cell death. 

  • PDT has proven ability to kill microbial cells, including bacteria, fungi and viruses. 

  • It is recognized as a treatment strategy that is both minimally invasive and minimally toxic.

  • Photodynamic therapy's advantages lessen the need for delicate surgery and lengthy recuperation and minimal formation of scar tissue and disfigurement.

​

Advantages for PDT:

​

  • It has no long-term side effects when used properly.

  • It’s less invasive than surgery.

  • It usually takes only a short time and is most often done as an outpatient.

  • It can be targeted very precisely.

  • Unlike radiation, PDT can be repeated many times at the same site if needed.

  • There’s usually little or no scarring after the site heals.

  • It costs less than other cancer treatments.

 

PDT Structure

​

  • Photodynamic therapy (PDT) relies on the combination of a photosensitive drug, known as a photosensitizer, with light of the proper wavelength and molecular oxygen to generate cytotoxic reactive oxygen species.

  • The synergy of drugs and devices represents an enormous and largely untapped potential for both clinical progress and corporate profit.

​​

factuel_lumiere-cancer.jpg
bottom of page